Trials / Recruiting
RecruitingNCT05877885
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- AdventHealth · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomized controlled trial is to evaluate the potential of a customized digital cognitive training intervention to target aspects of brain function in apathy of late-life depression and reduce symptoms of apathy and related cognitive and behavioral deficits. The investigators hypothesize that 4 weeks of a customized digital cognitive training program will lead to changes in brain connectivity, apathy severity, and cognitive control performance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Targeted Cognitive Training Intervention | In this intervention, participants will complete 25-30 minutes of cognitive training per day, 5 days/week (but up to 7 days/week) for 4 weeks. The training protocol will be delivered via the Posit Science Platform, and includes tasks that emphasize training of sustained attention, salience detection, and dimensions of cognitive control. During the 4 week intervention, participants will have weekly 10-20 minute visits with a Care Manager to provide clinical monitoring of symptoms and structured support to participants. |
| BEHAVIORAL | General Cognitive Training Intervention | In this intervention, participants will complete 25-30 minutes of cognitive activities per day, 5 days/week (but up to 7 days/week) for 4 weeks. The training protocol will be delivered via the Posit Science Platform. The intervention protocol will include computerized cognitive activities designed to provide general cognitive stimulation. During the 4 week intervention, participants will have weekly 10-20 minute visits with a Care Manager to provide clinical monitoring of symptoms and structured support to participants. |
Timeline
- Start date
- 2025-09-19
- Primary completion
- 2028-11-01
- Completion
- 2028-12-01
- First posted
- 2023-05-26
- Last updated
- 2025-10-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05877885. Inclusion in this directory is not an endorsement.